Literature DB >> 20087632

Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.

Denise Bechet1, Loraine Tirand, Béatrice Faivre, François Plénat, Corinne Bonnet, Thierry Bastogne, Céline Frochot, François Guillemin, Muriel Barberi-Heyob.   

Abstract

PURPOSE: This article characterizes the vascular effects following vascular-targeted photodynamic therapy with a photosensitizer which actively targets endothelial cells.
METHODS: This strategy was considered by coupling a chlorin to a heptapeptide targeting neuropilin-1 in human malignant glioma-bearing nude mice. A laser Doppler microvascular perfusion monitor was used to monitor microvascular blood perfusion in tumor tissue. Endothelial cells' ultra structural integrity was observed by transmission electron microscopy. The consequences of photosensitization on tumor vessels, tissue factor expression, fibrinogen consumption, and thrombogenic effects were studied by immunohistochemical staining.
RESULTS: Treatment of glioma-bearing mice with the conjugate showed a statistically significant tumor growth delay. Vascular effect was characterized by a decrease in tumor tissue blood flow at about 50% baseline during treatment not related to variations in temperature. This vascular shutdown was mediated by tumor blood vessels' congestion. A pro-thrombotic behavior of targeted endothelial cells in the absence of ultra structural changes led to the induction of tissue factor expression from the earliest times post-treatment. Expression of tissue factor-initiated thrombi formation was also related to an increase in fibrinogen consumption.
CONCLUSION: Using a peptide-conjugated photosensitizer targeting neuropilin-1, induction of tissue factor expression immediately post-treatment, led to the establishment of thrombogenic effects within the vessel lumen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087632     DOI: 10.1007/s11095-009-0035-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  48 in total

1.  Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.

Authors:  Fadila Chergui; Anne-Sophie Chrétien; Sanae Bouali; Carole Ramacci; Marie Rouyer; Thierry Bastogne; Pascal Genin; Agnès Leroux; Jean-Louis Merlin
Journal:  Clin Chem       Date:  2009-05-14       Impact factor: 8.327

2.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages.

Authors:  S Evans; W Matthews; R Perry; D Fraker; J Norton; H I Pass
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

3.  Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.

Authors:  Loraine Tirand; Noémie Thomas; Marc Dodeller; Dominique Dumas; Céline Frochot; Benoît Maunit; François Guillemin; Muriel Barberi-Heyob
Journal:  Drug Metab Dispos       Date:  2007-02-05       Impact factor: 3.922

4.  Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide.

Authors:  Debra K Kelleher; Oliver Thews; Avigdor Scherz; Yoram Salomon; Peter Vaupel
Journal:  Int J Oncol       Date:  2004-06       Impact factor: 5.650

Review 5.  Vascular effects of photodynamic therapy.

Authors:  V H Fingar
Journal:  J Clin Laser Med Surg       Date:  1996-10

6.  Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.

Authors:  Sophie Pinel; Muriel Barberi-Heyob; Elizabeth Cohen-Jonathan; Jean-Louis Merlin; Caroline Delmas; François Plenat; Pascal Chastagner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 8.  Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives.

Authors:  Martin E Eichhorn; Sebastian Strieth; Marc Dellian
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

9.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

10.  Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

Authors:  V H Fingar; P K Kik; P S Haydon; P B Cerrito; M Tseng; E Abang; T J Wieman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  12 in total

1.  Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis.

Authors:  Katarzyna A Uniewicz; Michael J Cross; David G Fernig
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

2.  Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma.

Authors:  Mickaël Gries; Noémie Thomas; Joël Daouk; Paul Rocchi; Laurence Choulier; Justine Jubréaux; Julien Pierson; Aurélie Reinhard; Valérie Jouan-Hureaux; Alicia Chateau; Samir Acherar; Céline Frochot; François Lux; Olivier Tillement; Muriel Barberi-Heyob
Journal:  Int J Nanomedicine       Date:  2020-11-09

3.  New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.

Authors:  Ezatul Ezleen Kamarulzaman; Amirah Mohd Gazzali; Samir Acherar; Céline Frochot; Muriel Barberi-Heyob; Cédric Boura; Patrick Chaimbault; Estelle Sibille; Habibah A Wahab; Régis Vanderesse
Journal:  Int J Mol Sci       Date:  2015-10-12       Impact factor: 5.923

4.  Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.

Authors:  Magali Toussaint; Sophie Pinel; Florent Auger; Nicolas Durieux; Magalie Thomassin; Eloise Thomas; Albert Moussaron; Dominique Meng; François Plénat; Marine Amouroux; Thierry Bastogne; Céline Frochot; Olivier Tillement; François Lux; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2017-01-05       Impact factor: 11.556

5.  Vascular targeted photodynamic therapy: A review of the efforts towards molecular targeting of tumor vasculature.

Authors:  Vida Mashayekhi; Charlotte Op 't Hoog; Sabrina Oliveira
Journal:  J Porphyr Phthalocyanines       Date:  2019-12       Impact factor: 1.811

Review 6.  Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR).

Authors:  Nichole E M Kaufman; Simran Dhingra; Seetharama D Jois; Maria da Graça H Vicente
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

7.  Multifunctional Peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI.

Authors:  Hamanou Benachour; Aymeric Sève; Thierry Bastogne; Céline Frochot; Régis Vanderesse; Jordane Jasniewski; Imen Miladi; Claire Billotey; Olivier Tillement; François Lux; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2012-09-29       Impact factor: 11.556

8.  Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1.

Authors:  Caifeng Gong; Julie Valduga; Alicia Chateau; Mylène Richard; Nadia Pellegrini-Moïse; Muriel Barberi-Heyob; Pascal Chastagner; Cédric Boura
Journal:  Oncotarget       Date:  2018-02-16

9.  Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.

Authors:  Eloïse Thomas; Ludovic Colombeau; Mickaël Gries; Thibaut Peterlini; Clélia Mathieu; Noémie Thomas; Cédric Boura; Céline Frochot; Régis Vanderesse; François Lux; Muriel Barberi-Heyob; Olivier Tillement
Journal:  Int J Nanomedicine       Date:  2017-09-26

10.  Functionalized Tobacco Mosaic Virus Coat Protein Monomers and Oligomers as Nanocarriers for Anti-Cancer Peptides.

Authors:  Coralie Gamper; Caroline Spenlé; Sonia Boscá; Michael van der Heyden; Mathieu Erhardt; Gertraud Orend; Dominique Bagnard; Manfred Heinlein
Journal:  Cancers (Basel)       Date:  2019-10-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.